Similarly, mitazalimab delivery 7 days prior to chemotherapy (FOLFRINOX) in metastatic PDAC patients caused fluctuations in DC (CD11c+) levels, but overall expansion of CD38+ NKT cells, which was significantly associated with a reduction in tumor size.80 The gene discussed is ITGAX; the disease is neoplasm.